Abstract
Belgium Wound Care Management Investment Opportunities, Analysis and Forecasts
to 2012
Summary
This report is an essential source for in-depth information and data relating
to Belgium wound care management market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the wound care management in
Belgium
Scope
・ The report provides wound care management information broken down into
detailed categories and segments in Belgium.
・ Total revenues, products
sold, end users, and average pricing.
・ Market shares of all the key
competitors.
・ Key pipeline products that are set to shape the market,
broken down by sector.
・ Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
・ Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the wound care management market in
Belgium.
・ Evaluate and compare the attractiveness of the market in the
country.
・ Identify growth segments and opportunities in each industry
sector within the country.
・ Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
・ Analyze the competitiveness of the
market in the country and identify hotspots.
・ Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What Is This Report About? 14
2.2 Definitions
14
2.2.1 Wound Care Management 14
3 Healthcare Sector Review 16
3.1 Healthcare Expenditure 16
3.2 Healthcare Infrastructure 18
3.2.1
Healthcare Personnel Data 19
3.2.2 Healthcare Facilities Data 20
3.3
Healthcare Policy 21
4 Wound Care Management in Belgium 23
4.1 Wound
Care Management Overall Revenues (2000-2012) 23
4.2 Wound Care Management
Overall Volume (2000-2012) 29
4.3 Wound Care Management Overall Company
Shares (2005-2006) 32
5 Wound Closure Devices in Belgium 33
5.1 Wound
Closure Devices Overall Revenues (2000-2012) 33
5.1.1 Skin Closure Devices
Overall Revenues (2000-2012) 37
5.1.2 Hemostats Overall Revenues
(2000-2012) 39
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 41
5.2 Wound Closure Devices Overall Volume (2000-2012) 43
5.2.1 Skin Closure
Devices Overall Volume (2000-2012) 45
5.2.2 Tissue Sealants Overall Volume
(2000-2012) 47
5.2.3 Hemostats Overall Volume (2000-2012) 49
5.3 Wound
Closure Devices Average Price (2000-2012) 51
5.3.1 Hemostats Average Price
(2000-2012) 51
5.3.2 Tissue Sealants Average Price (2000-2012) 53
5.3.3 Skin Closure Devices Average Price (2000-2012) 55
5.4 Wound Closure
Devices Distribution Share (2005-2006) 57
5.5 Wound Closure Devices
Company Share (2005-2006) 58
6 Ostomy in Belgium 59
6.1 Ostomy Overall
Revenue (2000-2012) 59
6.2 Ostomy Overall Volume (2000-2012) 61
6.3
Ostomy Average Price (2000-2012) 63
6.4 Ostomy Distribution Share
(2005-2006) 65
6.5 Ostomy Company Share (2005-2006) 66
7 Advanced
Wound Management in Belgium 67
7.1 Advanced Wound Management Overall
Revenue (2000-2012) 67
7.2 Advanced Wound Management Overall Volume
(2000-2012) 69
7.3 Advanced Wound Management Average Price (2000-2012)
71
7.4 Advanced Wound Management Distribution Share (2005-2006) 73
7.5
Advanced Wound Management Company Share (2005-2006) 74
8 Traditional Wound
Management 75
8.1 Traditional Wound Management Overall Revenue (2000-2012)
75
8.2 Traditional Wound Management Overall Volume (2000-2012) 77
8.3
Traditional Wound Management Average Price (2000-2012) 79
8.4 Traditional
Wound Management Distribution Share (2005-2006) 81
8.5 Traditional Wound
Management Company Share (2005-2006) 82
9 Compression Therapy in Belgium
83
9.1 Compression Therapy Overall Revenue (2000-2012) 83
9.2
Compression Therapy Overall Volume (2000-2012) 85
9.3 Compression Therapy
Average Price (2000-2012) 87
9.4 Compression Therapy Distribution Share
(2005-2006) 89
9.5 Compression Therapy Company Share (2005-2006) 90
10
Baxter International Company Profile 91
10.1 Company Overview 91
10.2
Business Overview 91
10.2.1 BioScience 91
10.2.2 Medication Delivery
91
10.2.3 Renal 92
10.2.4 Products 92
10.2.5 History 93
10.3
Value Chain Analysis 96
10.3.1 Manufacturing 96
10.3.2 Product
Development 97
10.3.3 Sales and Marketing 98
10.4 SWOT Analysis 99
10.4.1 Baxter International Inc. Strengths 99
10.4.2 Baxter International
Inc. Weaknesses 100
10.4.3 Baxter International Inc. Opportunities 100
10.4.4 Baxter International Inc. Threats 101
10.5 Financial and
Operational Review 102
10.6 Locations And Subsidiaries 103
10.7 Baxter
International Inc. Pipeline Products 105
10.7.1 Next-Generation Home
Hemodialysis Machine 105
11 The HARTMANN GROUP Company Profile 107
11.1 Company Overview 107
11.2 Business Overview 107
11.2.1
Incontinence Management 107
11.2.2 Operating Theater Management 107
11.2.3 Other GROUP Activities 108
11.2.4 Wound Management 108
11.2.5
Products 108
11.2.6 History 109
11.3 Value Chain Analysis 111
11.3.1 Manufacturing 111
11.3.2 Product Development 112
11.3.3 Sales
and Marketing 112
11.4 SWOT Analysis 112
11.4.1 HARTMANN GROUP
Strengths 113
11.4.2 HARTMANN GROUP Weaknesses 113
11.4.3 HARTMANN
GROUP Opportunities 114
11.4.4 HARTMANN GROUP Threats 114
11.5
Financial and Operational Review 116
11.6 Locations And Subsidiaries
117
12 Coloplast A/S Company Profile 119
12.1 Company Overview 119
12.2 Business Overview 119
12.2.1 Medical Care 119
12.2.2 Major
Products and Services 120
12.2.3 History 120
12.3 Value Chain Analysis
122
12.3.1 Manufacturing 122
12.3.2 Product Development 122
12.3.3
Sales and Marketing 124
12.4 SWOT Analysis 124
12.4.1 Coloplast A/S
Strengths 125
12.4.2 Coloplast A/S Weaknesses 125
12.4.3 Coloplast A/S
Opportunities 126
12.4.4 Coloplast A/S Threats 127
12.5 Financial and
Operational Review 128
12.5.1 Financial Statements 128
12.5.2
Financial Ratios 129
12.5.3 Share Holding Structure 129
12.6 Locations
And Subsidiaries 130
13 ConvaTec Company Profile 132
13.1 Company
Overview 132
13.2 Business Overview 132
13.2.1 Major Products and
Services 132
13.2.2 History 133
13.3 Locations And Subsidiaries
134
14 Ethicon, Inc. Company Profile 135
14.1 Company Overview 135
14.2 Business Overview 135
14.2.1 Products 136
14.3 Locations And
Subsidiaries 136
15 Regulation System 138
15.1 Medical Equipment
Approval Process 138
15.1.1 Classification 139
15.1.2 Conformity
Assessment Process 148
15.2 Notification Fee 152
16 Pricing and
Reimbursement 153
16.1 Reimbursement Policies 153
17 Distribution
Structure 154
18 Appendix 155
18.1 Global Markets Direct Research
Methodology 155
18.2 Coverage 156
18.3 Secondary Research 156
18.4
Primary Research 157
18.5 Models 157
18.6 Forecasts 158
18.7
Expert Panels 158
18.8 Currency Conversion 159
18.9 Contact Us 160
18.10 Disclaimer 160
1.1 List of Tables
Table 1: Hospitals and
Hospital Beds in Belgium, 2005 18
Table 2: Number of Doctors by Specialty
in Belgium, 2003-2007 19
Table 3: Number of Hospital Wards by Specialty in
Belgium, 2003-2007 20
Table 4: Wound Care Management, Belgium, Overall
Revenues ($ mn), 2000-2012 23
Table 5: Wound Care Management, Belgium,
Overall Revenues ($ mn), Historic, 2000-2007 24
Table 6: Wound Care
Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 25
Table
7: Wound Care Management, Belgium, Category Revenues ($ mn), 2000-2012 26
Table 8: Wound Care Management, Belgium, Category Revenues ($ mn), Historic,
2000-2007 27
Table 9: Wound Care Management, Belgium, Category Revenues ($
mn), Forecast, 2007-2012 28
Table 10: Wound Care Management, Belgium,
Category Volume (Units), 2000-2012 29
Table 11: Wound Care Management,
Belgium, Category Volume (Units), Historic, 2000-2007 30
Table 12: Wound
Care Management, Belgium, Category Volume (Units), Forecast, 2007-2012 31
Table 13: Wound Care Management, Belgium, Company Share by Revenue ($ mn),
2005-2006 32
Table 14: Wound Closure Devices, Belgium, Overall Revenues ($
mn), Historic, 2000-2007 33
Table 15: Wound Closure Devices, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 34
Table 16: Wound Closure
Devices, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007 35
Table
17: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Forecast,
2007-2012 36
Table 18: Skin Closure Devices, Belgium, Overall Revenues ($
mn), Historic, 2000-2007 37
Table 19: Skin Closure Devices, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 38
Table 20: Hemostats,
Belgium, Overall Revenues ($ mn), Historic, 2000-2007 39
Table 21:
Hemostats, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 40
Table
22: Tissue Sealants, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
41
Table 23: Tissue Sealants, Belgium, Overall Revenues ($ mn), Forecast,
2007-2012 42
Table 24: Wound Closure Devices, Belgium, Overall Volume
(Units), Historic, 2000-2007 43
Table 25: Wound Closure Devices, Belgium,
Overall Volume (Units), Forecast, 2007-2012 44
Table 26: Skin Closure
Devices, Belgium, Overall Volume (Units), Historic, 2000-2007 45
Table 27:
Skin Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012
46
Table 28: Tissue Sealants, Belgium, Overall Volume (Units), Historic,
2000-2007 47
Table 29: Tissue Sealants, Belgium, Overall Volume (Units),
Forecast, 2007-2012 48
Table 30: Hemostats, Belgium, Overall Volume
(Units), Historic, 2000-2007 49
Table 31: Hemostats, Belgium, Overall
Volume (Units), Forecast, 2007-2012 50
Table 32: Hemostats, Belgium,
Average Price ($), Historic, 2000-2007 51
Table 33: Hemostats, Belgium,
Average Price ($), Forecast, 2007-2012 52
Table 34: Tissue Sealants,
Belgium, Average Price ($), Historic, 2000-2007 53
Table 35: Tissue
Sealants, Belgium, Average Price ($), Forecast, 2007-2012 54
Table 36:
Skin Closure Devices, Belgium, Average Price ($), Historic, 2000-2007 55
Table 37: Skin Closure Devices, Belgium, Average Price ($), Forecast,
2007-2012 56
Table 38: Wound Closure Devices, Belgium, Distribution Share
by Revenue ($ mn), 2005-2006 57
Table 39: Wound Closure Devices, Belgium,
Company Share by Revenue ($ mn), 2005-2006 58
Table 40: Ostomy, Belgium,
Overall Revenues ($ mn), Historic, 2000-2007 59
Table 41: Ostomy, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 60
Table 42: Ostomy, Belgium,
Overall Volume (Units), Historic, 2000-2007 61
Table 43: Ostomy, Belgium,
Overall Volume (Units), Forecast, 2007-2012 62
Table 44: Ostomy, Belgium,
Average Price ($), Historic, 2000-2007 63
Table 45: Ostomy, Belgium,
Average Price ($), Forecast, 2007-2012 64
Table 46: Ostomy, Belgium,
Distribution Share by Revenue ($ mn), 2005-2006 65
Table 47: Ostomy,
Belgium, Company Share by Revenue ($ mn), 2005-2006 66
Table 48: Advanced
Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007 67
Table 49: Advanced Wound Management, Belgium, Overall Revenues ($ mn),
Forecast, 2007-2012 68
Table 50: Advanced Wound Management, Belgium,
Overall Volume (Units), Historic, 2000-2007 69
Table 51: Advanced Wound
Management, Belgium, Overall Volume (Units), Forecast, 2007-2012 70
Table
52: Advanced Wound Management, Belgium, Average Price ($), Historic, 2000-2007
71
Table 53: Advanced Wound Management, Belgium, Average Price ($),
Forecast, 2007-2012 72
Table 54: Advanced Wound Management, Belgium,
Distribution Share by Revenue ($ mn), 2005-2006 73
Table 55: Advanced
Wound Management, Belgium, Company Share by Revenue ($ mn), 2005-2006 74
Table 56: Traditional Wound Management, Belgium, Overall Revenues ($ mn),
Historic, 2000-2007 75
Table 57: Traditional Wound Management, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 76
Table 58: Traditional
Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007 77
Table 59: Traditional Wound Management, Belgium, Overall Volume (Units),
Forecast, 2007-2012 78
Table 60: Traditional Wound Management, Belgium,
Average Price ($), Historic, 2000-2007 79
Table 61: Traditional Wound
Management, Belgium, Average Price ($), Forecast, 2007-2012 80
Table 62:
Traditional Wound Management, Belgium, Distribution Share by Revenue ($ mn),
2005-2006 81
Table 63: Traditional Wound Management, Belgium, Company
Share by Revenue ($ mn), 2005-2006 82
Table 64: Compression Therapy,
Belgium, Overall Revenues ($ mn), Historic, 2000-2007 83
Table 65:
Compression Therapy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012
84
Table 66: Compression Therapy, Belgium, Overall Volume (Units),
Historic, 2000-2007 85
Table 67: Compression Therapy, Belgium, Overall
Volume (Units), Forecast, 2007-2012 86
Table 68: Compression Therapy,
Belgium, Average Price ($), Historic, 2000-2007 87
Table 69: Compression
Therapy, Belgium, Average Price ($), Forecast, 2007-2012 88
Table 70:
Compression Therapy, Belgium, Distribution Share by Revenue ($ mn), 2005-2006
89
Table 71: Compression Therapy, Belgium, Company Share by Revenue ($
mn), 2005-2006 90
Table 72: Baxter International Inc., SWOT Analysis,
2006 99
Table 73: Baxter International Inc., Financial Statements,
USD Million, 2002-2006 102
Table 74: Baxter International Inc.,
Financial Ratios, USD Million, 2002-2006 103
Table 75: Baxter
International Inc., Other Locations 104
Table 76: Baxter
International Inc., Subsidiaries 105
Table 77: HARTMANN GROUP, SWOT
Analysis, 2006 112
Table 78: HARTMANN GROUP, Financial Statements,
Euro Thousand, 2002-2006 116
Table 79: HARTMANN GROUP, Financial
Ratios, Euro Thousand, 2002-2006 117
Table 80: HARTMANN GROUP,
Subsidiaries 118
Table 81: Coloplast A/S, SWOT Analysis, 2007 124
Table 82: Coloplast A/S, Financial Statements, DKK Million, 2003-2007
128
Table 83: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007
129
Table 84: Coloplast A/S, Share Holding Structure 129
Table
85: Coloplast A/S, Other Locations 130
Table 86: Coloplast A/S,
Subsidiaries 130
Table 87: Coloplast A/S, Subsidiaries(Contd.)
131
Table 88: ConvaTec, Other Locations 134
Table 89:
Ethicon, Inc., Other Locations 137
Table 90: Ethicon, Inc.,
Subsidiaries 137
Table 91: Medical Equipment Notification Fee in Belgium,
2007 152
Table 92: Currency Conversion from USD to Local Currency at
2007 Constant Rate 159
1.2 List of Figures
Figure 1: Total
Healthcare Expenditure in Belgium, 2000 -- 2006 17
Figure 2: Structure of
Healthcare System in Belgium, 2007 22
Figure 3: Wound Care Management,
Belgium, Overall Revenues ($ mn), 2000-2012 23
Figure 4: Wound Care
Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007 24
Figure 5: Wound Care Management, Belgium, Overall Revenues ($ mn), Forecast,
2007-2012 25
Figure 6: Wound Care Management, Belgium, Category Revenues
($ mn), 2000-2012 26
Figure 7: Wound Care Management, Belgium, Category
Revenues ($ mn), Historic, 2000-2007 27
Figure 8: Wound Care Management,
Belgium, Category Revenues ($ mn), Forecast, 2007-2012 28
Figure 9: Wound
Care Management, Belgium, Category Volume (Units), 2000-2012 29
Figure 10:
Wound Care Management, Belgium, Category Volume (Units), Historic, 2000-2007
30
Figure 11: Wound Care Management, Belgium, Category Volume (Units),
Forecast, 2007-2012 31
Figure 12: Wound Care Management, Belgium, Company
Share (%), 2006 32
Figure 13: Wound Closure Devices, Belgium, Overall
Revenues ($ mn), Historic, 2000-2007 33
Figure 14: Wound Closure Devices,
Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 34
Figure 15: Wound
Closure Devices, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007
35
Figure 16: Wound Closure Devices, Belgium, Revenue by Segment ($ mn),
Forecast, 2007-2012 36
Figure 17: Skin Closure Devices, Belgium, Overall
Revenues ($ mn), Historic, 2000-2007 37
Figure 18: Skin Closure Devices,
Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 38
Figure 19:
Hemostats, Belgium, Overall Revenues ($ mn), Historic, 2000-2007 39
Figure
20: Hemostats, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012 40
Figure 21: Tissue Sealants, Belgium, Overall Revenues ($ mn), Historic,
2000-2007 41
Figure 22: Tissue Sealants, Belgium, Overall Revenues ($ mn),
Forecast, 2007-2012 42
Figure 23: Wound Closure Devices, Belgium, Overall
Volume (Units), Historic, 2000-2007 43
Figure 24: Wound Closure Devices,
Belgium, Overall Volume (Units), Forecast, 2007-2012 44
Figure 25: Skin
Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007 45
Figure 26: Skin Closure Devices, Belgium, Overall Volume (Units), Forecast,
2007-2012 46
Figure 27: Tissue Sealants, Belgium, Overall Volume (Units),
Historic, 2000-2007 47
Figure 28: Tissue Sealants, Belgium, Overall Volume
(Units), Forecast, 2007-2012 48
Figure 29: Hemostats, Belgium, Overall
Volume (Units), Historic, 2000-2007 49
Figure 30: Hemostats, Belgium,
Overall Volume (Units), Forecast, 2007-2012 50
Figure 31: Hemostats,
Belgium, Average Price ($), Historic, 2000-2007 51
Figure 32: Hemostats,
Belgium, Average Price ($), Forecast, 2007-2012 52
Figure 33: Tissue
Sealants, Belgium, Average Price ($), Historic, 2000-2007 53
Figure 34:
Tissue Sealants, Belgium, Average Price ($), Forecast, 2007-2012 54
Figure
35: Skin Closure Devices, Belgium, Average Price ($), Historic, 2000-2007
55
Figure 36: Skin Closure Devices, Belgium, Average Price ($), Forecast,
2007-2012 56
Figure 37: Wound Closure Devices, Belgium, Distribution Share
(%), 2006 57
Figure 38: Wound Closure Devices, Belgium, Company Share (%),
2006 58
Figure 39: Ostomy, Belgium, Overall Revenues ($ mn), Historic,
2000-2007 59
Figure 40: Ostomy, Belgium, Overall Revenues ($ mn),
Forecast, 2007-2012 60
Figure 41: Ostomy, Belgium, Overall Volume (Units),
Historic, 2000-2007 61
Figure 42: Ostomy, Belgium, Overall Volume (Units),
Forecast, 2007-2012 62
Figure 43: Ostomy, Belgium, Average Price ($),
Historic, 2000-2007 63
Figure 44: Ostomy, Belgium, Average Price ($),
Forecast, 2007-2012 64
Figure 45: Ostomy, Belgium, Company Share (%), 2006
66
Figure 46: Advanced Wound Management, Belgium, Overall Revenues ($ mn),
Historic, 2000-2007 67
Figure 47: Advanced Wound Management, Belgium,
Overall Revenues ($ mn), Forecast, 2007-2012 68
Figure 48: Advanced Wound
Management, Belgium, Overall Volume (Units), Historic, 2000-2007 69
Figure
49: Advanced Wound Management, Belgium, Overall Volume (Units), Forecast,
2007-2012 70
Figure 50: Advanced Wound Management, Belgium, Average Price
($), Historic, 2000-2007 71
Figure 51: Advanced Wound Management, Belgium,
Average Price ($), Forecast, 2007-2012 72
Figure 52: Advanced Wound
Management, Belgium, Distribution Share (%), 2006 73
Figure 53: Advanced
Wound Management, Belgium, Company Share (%), 2006 74
Figure 54:
Traditional Wound Management, Belgium, Overall Revenues ($ mn), Historic,
2000-2007 75
Figure 55: Traditional Wound Management, Belgium, Overall
Revenues ($ mn), Forecast, 2007-2012 76
Figure 56: Traditional Wound
Management, Belgium, Overall Volume (Units), Historic, 2000-2007 77
Figure
57: Traditional Wound Management, Belgium, Overall Volume (Units), Forecast,
2007-2012 78
Figure 58: Traditional Wound Management, Belgium, Average
Price ($), Historic, 2000-2007 79
Figure 59: Traditional Wound Management,
Belgium, Average Price ($), Forecast, 2007-2012 80
Figure 60: Traditional
Wound Management, Belgium, Distribution Share (%), 2006 81
Figure 61:
Traditional Wound Management, Belgium, Company Share (%), 2006 82
Figure
62: Compression Therapy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007
83
Figure 63: Compression Therapy, Belgium, Overall Revenues ($ mn),
Forecast, 2007-2012 84
Figure 64: Compression Therapy, Belgium, Overall
Volume (Units), Historic, 2000-2007 85
Figure 65: Compression Therapy,
Belgium, Overall Volume (Units), Forecast, 2007-2012 86
Figure 66:
Compression Therapy, Belgium, Average Price ($), Historic, 2000-2007 87
Figure 67: Compression Therapy, Belgium, Average Price ($), Forecast,
2007-2012 88
Figure 68: Compression Therapy, Belgium, Distribution Share
(%), 2006 89
Figure 69: Compression Therapy, Belgium, Company Share (%),
2006 90
Figure 70: Baxter International Inc., Value Chain Analysis
96
Figure 71: HARTMANN GROUP, Value Chain Analysis 111
Figure 72:
Coloplast A/S, Value Chain Analysis 122
Figure 73: Flowchart for
Classification of Non-invasive Devices in Belgium, 2007 140
Figure 74:
Flowchart for Classification of Invasive Devices in Belgium, 2007 141
Figure 75: Flowchart for Classification of Invasive Devices in Belgium, 2007
142
Figure 76: Flowchart for Classification of Invasive Devices in
Belgium, 2007 143
Figure 77: Flowchart for Classification of Invasive
Devices in Belgium, 2007 144
Figure 78: Flowchart for Classification of
Active Devices in Belgium, 2007 145
Figure 79: Flowchart for
Classification of Active Devices in Belgium, 2007 146
Figure 80: Flowchart
for Classification of Devices except Non-invasive, Invasive and Active Devices
in Belgium, 2007 147
Figure 81: Conformity Assessment of Class-I Medical
Devices in Belgium, 2007 148
Figure 82: Conformity Assessment of Class-IIa
Medical Devices in Belgium, 2007 149
Figure 83: Conformity Assessment of
Class-IIb Medical Devices in Belgium, 2007 150
Figure 84: Conformity
Assessment of Class-III Medical Devices in Belgium, 2007 151
Figure 85:
Global Markets Direct Methodology 155
|
